Search results
Author(s):
Charles Simonton
,
Craig Thompson
,
Jason R Wollmuth
,
et al
Added:
3 years ago
Coronary artery disease (CAD) is a leading cause of morbidity and mortality globally, despite advances in medical and preventive therapy. It is estimated that 18.2 million adults in the US have CAD, with 720,000 Americans projected to have a first hospitalization for MI or CAD death this year.1 Treatment of patients with symptomatic CAD includes guideline-directed medical therapy and coronary…
View more
Author(s):
Ahmed M Alabbady
,
Ahmed S Abdul-Al
,
Kimberly A Skelding
Added:
3 years ago
The introduction of percutaneous coronary angioplasty in 1977 by Dr Andreas Grüntzig1 was one of the most remarkable achievements in the cardiology realm, opening the door to numerous advancements in percutaneous coronary interventions (PCIs). Due to advances in PCI techniques over the past four decades, catheters along with four generations of coronary stents have dramatically changed the…
View more
Author(s):
Andrea Elliott
,
Garima Dahyia
,
Rajat Kalra
,
et al
Added:
2 years ago
Author(s):
Rani Upadhyay
,
Hussayn Alrayes
,
Scott Arno
,
et al
Added:
2 years ago
Christian Inchaustegui
Author
Author(s):
Petr Ostadal
,
Saahil A Jumkhawala
Added:
1 year ago
AHA 22 - CardioNerds Fellow, Dr Saahil A Jumkhawala (Rutgers New Jersey Medical School, US) is joined by investigator, Dr Petr Ostadal (Na Homolce Hospital, CZ) to talk about the ECMO-CS trial (NCT02301819).
In the ECMO-CS trial 122 patients with rapidly deteriorating or severe cardiogenic shock were randomized to receive veno-arterial extracorporeal membrane oxygenation (ECMO) or early…
View more
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
7 months ago
What is hot at ESC 2023?
In this episode of View of the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, NL) preview the hot line and late-breaking data presented at ESC Congress 2023.
With their dynamic analysis, they place these highly anticipated trials within a context, highlighting the real-world implications tied to the data releases.
Top trials…
View more
Author(s):
Shahana Uddin
,
Rathai Anandanadesan
,
Richard Trimlett
,
et al
Added:
1 year ago
Federico Pappalardo
Author
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
1 year ago
In this dynamic late-breaking science preview Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) share their take on the most anticipated trials of the AHA Scientific Sessions.
What late-breaking trials should we look out for? Which results are likely to impact your practice? What are the considerations and challenges?
Trials covered in detail include:
37s:…
View more